{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:29:54Z","timestamp":1791815394073,"version":"4.3.4"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is characterized by multiple clinical manifestations. Vasculopathy is a main disease hallmark and ranges in severity from an exacerbated Raynaud phenomenon to pulmonary arterial hypertension (PAH). The potential involvement of the immune system in SSc-associated vascular abnormalities is not clear. Here, we set out to study SSc-related immune parameters and determine whether and which peripheral T cell subsets associate with vascular severity in SSc patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Peripheral blood and clinical data were collected from 30 SSc patients, 5 patients with idiopathic PAH and 15 age and sex-matched healthy donors (HD). In this cross-sectional cohort, SSc patients with PAH (n\u2009=\u200915) were matched for their age, sex and medication with SSc patients with no signs of PAH (n\u2009=\u200915). Lymphocyte subsets were quantified by multi-colour flow cytometry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>SSc patients exhibited elevated percentages of T peripheral helper cells (Tph), CD4+GZMB+ T cells and decreased levels of Th1 cells compared with HD. Increased presence of both CD4+ and CD8+ exhausted-like (CD28\u2212) T cells, characterized by raised cytokine and cytotoxic signature, was also observed in SSc compared with HD blood. Furthermore, IL-4 expressing CD4+CD8+ T cells were significantly increased in SSc peripheral blood. Interestingly, the presence of PAH in SSc was accompanied by a distinct T helper profile, characterized by raised percentages of Th17 and Tph cells.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>SSc patients with severe vasculopathy (presence of PAH) exhibited a distinct T cell profile, suggesting a potential role of auto-immune inflammation in SSc vascular complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae190","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T22:56:36Z","timestamp":1711752996000},"page":"2525-2534","source":"Crossref","is-referenced-by-count":13,"title":["Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-4838","authenticated-orcid":false,"given":"Theodoros Ioannis","family":"Papadimitriou","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"},{"name":"Department of Laboratory Medicine \u2013 Medical Immunology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-5049","authenticated-orcid":false,"given":"Jacqueline M J","family":"Lemmers","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan P M","family":"van Caam","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline L","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly L","family":"Vitters","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizan","family":"Stinissen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-069X","authenticated-orcid":false,"given":"Sander I","family":"van Leuven","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije I","family":"Koenders","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"van der Kraan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J P M","family":"Koenen","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine \u2013 Medical Immunology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben L","family":"Smeets","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine \u2013 Medical Immunology, Radboudumc , Nijmegen, The Netherlands"},{"name":"Radboudumc Laboratory for Diagnostics, Department of Laboratory Medicine, Radboud University Medical Center , Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-6363","authenticated-orcid":false,"given":"Robin","family":"Nijveldt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon C","family":"Vonk","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier M","family":"Thurlings","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2024090322074160400_keae190-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2024090322074160400_keae190-B2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/biomedicines10020316","article-title":"Therapeutic options for systemic sclerosis: current and future perspectives in tackling immune-mediated fibrosis","volume":"10","author":"Papadimitriou","year":"2022","journal-title":"Biomedicines"},{"key":"2024090322074160400_keae190-B3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2024090322074160400_keae190-B4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/diagnostics11050911","article-title":"Systemic sclerosis-associated pulmonary hypertension: spectrum and impact","volume":"11","author":"Naranjo","year":"2021","journal-title":"Diagnostics"},{"key":"2024090322074160400_keae190-B5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"European heart journal"},{"key":"2024090322074160400_keae190-B6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the spectrum of pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"key":"2024090322074160400_keae190-B7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2024090322074160400_keae190-B8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J Clin Invest"},{"key":"2024090322074160400_keae190-B9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2022.03.011","article-title":"LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma","volume":"185","author":"Gur","year":"2022","journal-title":"Cell"},{"key":"2024090322074160400_keae190-B10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard-2023-224827","article-title":"CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion","volume":"83","author":"Papadimitriou","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024090322074160400_keae190-B11","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2024090322074160400_keae190-B12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfm\u00fcller","year":"2003","journal-title":"Eur Respir J"},{"key":"2024090322074160400_keae190-B13","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"2024090322074160400_keae190-B14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.humpath.2006.11.022","article-title":"Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases","volume":"38","author":"Dorfm\u00fcller","year":"2007","journal-title":"Hum Pathol"},{"key":"2024090322074160400_keae190-B15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00151829-200403060-00002","article-title":"Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management","volume":"3","author":"Ramirez","year":"2004","journal-title":"Treat Respir Med"},{"key":"2024090322074160400_keae190-B16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2017.10.002","article-title":"Current perspectives on the role of CD8+ T cells in systemic sclerosis","volume":"195","author":"Fuschiotti","year":"2018","journal-title":"Immunol Lett"},{"key":"2024090322074160400_keae190-B17","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T cells in systemic sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front Immunol"},{"key":"2024090322074160400_keae190-B18","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.3390\/ijms21197100","article-title":"Blocking IL-17: A promising strategy in the treatment of systemic rheumatic diseases","volume":"21","author":"Rafael-Vidal","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024090322074160400_keae190-B19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2024090322074160400_keae190-B20"},{"key":"2024090322074160400_keae190-B21","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2024090322074160400_keae190-B22","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2024090322074160400_keae190-B23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11926-000-0025-7","article-title":"The Th1\/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide","volume":"2","author":"Oliver","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"2024090322074160400_keae190-B24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-020-00529-z","article-title":"Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases","volume":"18","author":"Yoshitomi","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2024090322074160400_keae190-B25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","article-title":"Unraveling SSc Pathophysiology; The Myofibroblast","volume":"9","author":"van Caam","year":"2018","journal-title":"Front Immunol"},{"key":"2024090322074160400_keae190-B26","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2024090322074160400_keae190-B27","first-page":"Unit10.17","article-title":"Web-based analysis and publication of flow cytometry experiments","author":"Kotecha","year":"2010","journal-title":"Curr Protoc Cytom"},{"key":"2024090322074160400_keae190-B28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"2024090322074160400_keae190-B29","doi-asserted-by":"crossref","first-page":"977394","DOI":"10.3389\/fimmu.2022.977394","article-title":"T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"2024090322074160400_keae190-B30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6","article-title":"CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems","volume":"44","author":"Warrington","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2024090322074160400_keae190-B31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-020-02383-w","article-title":"Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis","volume":"23","author":"Fox","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2024090322074160400_keae190-B32","doi-asserted-by":"crossref","first-page":"154799","DOI":"10.1016\/j.cyto.2019.154799","article-title":"Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis","volume":"125","author":"Gasparini","year":"2020","journal-title":"Cytokine"},{"key":"2024090322074160400_keae190-B33","doi-asserted-by":"crossref","first-page":"977394","DOI":"10.3389\/fimmu.2022.977394","article-title":"T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"2024090322074160400_keae190-B34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"key":"2024090322074160400_keae190-B35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cei.13577","article-title":"Exhausted T cells in systemic lupus erythematosus patients in long-standing remission","volume":"204","author":"Lima","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"2024090322074160400_keae190-B36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J Clin Invest"},{"key":"2024090322074160400_keae190-B37","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3389\/fimmu.2020.01602","article-title":"Systemic Sclerosis Perturbs the Architecture of the Immunome","volume":"11","author":"Paleja","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"2024090322074160400_keae190-B38","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","article-title":"Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study","volume":"32","author":"Rodr\u00edguez-Reyna","year":"2012","journal-title":"Rheumatol Int"},{"key":"2024090322074160400_keae190-B39","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"2024090322074160400_keae190-B40","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2024090322074160400_keae190-B41","doi-asserted-by":"crossref","first-page":"885609","DOI":"10.3389\/fimmu.2022.885609","article-title":"The Yin and Yang of IL-17 in Systemic Sclerosis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"},{"key":"2024090322074160400_keae190-B42","doi-asserted-by":"crossref","first-page":"102515","DOI":"10.1016\/j.autrev.2020.102515","article-title":"Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels","volume":"19","author":"Smeets","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2024090322074160400_keae190-B43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5582\/irdr.2017.01044","article-title":"Pulmonary hypertension associated with antiphospholipid antibody: call for a screening tool?","volume":"6","author":"Parthvi","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"2024090322074160400_keae190-B44","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.autrev.2018.06.009","article-title":"Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma\u2014A review","volume":"17","author":"Nunes","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2024090322074160400_keae190-B45","doi-asserted-by":"crossref","first-page":"680109","DOI":"10.3389\/fcvm.2021.680109","article-title":"Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production","volume":"8","author":"Shu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024090322074160400_keae190-B46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/annrheumdis-2018-214382","article-title":"Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib","volume":"78","author":"Ricard","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024090322074160400_keae190-B47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCULATIONAHA.122.059949","article-title":"Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension","volume":"146","author":"Zhong","year":"2022","journal-title":"Circulation"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae190\/57553618\/keae190.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/9\/2525\/59007232\/keae190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/9\/2525\/59007232\/keae190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:45:33Z","timestamp":1725446733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/9\/2525\/7637682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,3,29]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae190","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,3,29]]}}}